PDGFRB and melanoma: In melanoma, the transfer of PDGFR-β mediated by EVs released by melanoma (donor) cells caused an activation of the PI3K/Akt pathway and escape from the MAPK pathway on BRAF mutated (recipient) cells, contributing to cellular proliferation and inhibition of apoptosis [50].